Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
ESSA Pharma Inc is a pharmaceutical company. The company is in the preclinical stage, focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer. The company is developing drugs that selectively block the amino-terminal domain of the androgen recepto... ESSA Pharma Inc is a pharmaceutical company. The company is in the preclinical stage, focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer. The company is developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Mehr anzeigen
ESSA Pharma Announces Termination of Phase 2 Study Evaluating Masofaniten Combined with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer PR Newswire SOUTH SAN...
ESSA Pharma Presents Updated Phase 1/2 Masofaniten (EPI-7386) Clinical Data at the 2024 ESMO Congress PR Newswire SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC, Sept. 13, 2024 Combination of...
ESSA Pharma to Present at the 2024 Cantor Global Healthcare Conference PR Newswire SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC, Sept. 11, 2024 SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.03 | -1.68539325843 | 1.78 | 1.85 | 1.73 | 246474 | 1.77545923 | CS |
| 4 | 0.13 | 8.02469135802 | 1.62 | 1.89 | 1.6 | 541173 | 1.75634258 | CS |
| 12 | -4.02 | -69.6707105719 | 5.77 | 7.69 | 1.4 | 880075 | 1.67781642 | CS |
| 26 | -5.07 | -74.3401759531 | 6.82 | 7.69 | 1.4 | 437264 | 1.91695389 | CS |
| 52 | -3.69 | -67.8308823529 | 5.44 | 11.67 | 1.4 | 275050 | 3.18549225 | CS |
| 156 | -11.17 | -86.4551083591 | 12.92 | 14.88 | 1.4 | 487107 | 4.26301022 | CS |
| 260 | -4 | -69.5652173913 | 5.75 | 36 | 1.4 | 376554 | 6.98878069 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
